Frequently Asked Questions

Showing FAQs tagged: false-positive · View all

CarePlus vs Alternatives

Yes — for raw screening throughput, AI is usually faster and lower marginal cost than having a human eye specialist read every image. But throughput is not the same as a complete primary care workflow.

When immediacy at the point of care matters: CarePlus can provide an AI-assisted, risk-based assessment so staff and clinicians get a same-visit signal while the patient is still in clinic.

When reliability and downstream cost matter: CarePlus routes images to licensed eye specialists (board-certified ophthalmologists or optometrists) for asynchronous interpretation. That approach reduces false-positive noise, unnecessary urgent referrals, and follow-up burden — costs that pure AI-only screening can create when sensitivity is tuned aggressively.

Practical summary for buyers:

  • Want a fast first-pass result during the visit → AI-assisted triage can help
  • Want a defensible clinical read and quality documentation → specialist interpretation and structured reporting
  • Want both → CarePlus supports a workflow-first model: capture in primary care, AI where it adds speed, specialist reads where clinical interpretation and reporting matter

HealthOcta provides the CarePlus technology platform and workflow; independent specialists perform clinical interpretation. Your clinic remains the treating provider.